Djalila Mekahli

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Exploring urinary allantoin and adenosine in pediatric autosomal dominant polycystic kidney disease: no clear association with disease severity.

Exploring urinary allantoin and adenosine in pediatric autosomal dominant polycystic kidney disease: no clear association with disease severity.

Journal: Pediatric nephrology (Berlin, Germany)

Published: February 04, 2026

KDIGO 2025 ADPKD guideline through pediatric eyes.

KDIGO 2025 ADPKD guideline through pediatric eyes.

Journal: Pediatric nephrology (Berlin, Germany)

Published: November 05, 2025

Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.

Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40.

Journal: Pediatric nephrology (Berlin, Germany)

Published: July 09, 2024

Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.

Clinical practice recommendations for kidney involvement in tuberous sclerosis complex: a consensus statement by the ERKNet Working Group for Autosomal Dominant Structural Kidney Disorders and the ERA Genes & Kidney Working Group.

Journal: Nature reviews. Nephrology

Published: February 08, 2024

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan.

Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan.

Journal: Pediatric nephrology (Berlin, Germany)

Published: July 11, 2023

Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients.

Low agreement between various eGFR formulae in pediatric and young adult ADPKD patients.

Journal: Pediatric nephrology (Berlin, Germany)

Published: October 18, 2022

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.

Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease.

Journal: BMC nephrology

Published: September 13, 2022

Correction to: Is autosomal dominant polycystic kidney disease an early sweet disease?

Correction to: Is autosomal dominant polycystic kidney disease an early sweet disease?

Journal: Pediatric nephrology (Berlin, Germany)

Published: June 21, 2022

Is autosomal dominant polycystic kidney disease an early sweet disease?

Is autosomal dominant polycystic kidney disease an early sweet disease?

Journal: Pediatric nephrology (Berlin, Germany)

Published: September 06, 2021

Correction to: The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.

Correction to: The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.

Journal: Pediatric nephrology (Berlin, Germany)

Published: August 24, 2021

Translational research approaches to study pediatric polycystic kidney disease.

Translational research approaches to study pediatric polycystic kidney disease.

Journal: Molecular and cellular pediatrics

Published: June 20, 2021

The red lipstick mentor.

The red lipstick mentor.

Journal: Pediatric nephrology (Berlin, Germany)

Published: April 01, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026